Objectives: 1. Discuss newer toxins emerged into the clinical scene.
2. Differentiate these newer toxins and show the clinical evidence that has entered into the public domain with respect to these toxins.

Introduction: Botulinum toxin A transformed the aesthetic and cosmetic arena into heights that no one saw coming when the first toxin was approved many years ago.

Results: Newer toxins have emerged into the clinical scene and this presentation will differentiate these newer toxins and show the clinical evidence that has entered into the public domain with respect to these toxins.

Conclusion: In addition, several newer toxins are in clinical trials at this time, and preliminary, public domain data will also be presented. It is an exciting time still for toxins for cosmetic use and we will focus on how some of these newer toxins may make a difference for our patients.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): Allergan, Galderma, Merz Aesthetics, Revance, Croma

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): Allergan, Galderma, Merz Aesthetics, Revance, Croma

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: Allergan, Galderma, Merz Aesthetics, Revance, Croma

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability